REFIL-2NCT07695363
Restrictive Fluid Management In Liver Transplantation (REFIL)
At risk: Primary completion moved at least 6 months later, primary endpoint(s) modified.
See at-risk trials from Centre hospitalier de l'Université de Montréal (CHUM)
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Nov 2030 to Jun 1, 2031 Show 8 more changesShow less
- Primary endpoint(s) modified
- Enrollment increased: 866 → 1364 participants
- Eligibility criteria shortened, about 16 words
- Study completion pushed from Nov 2031 to Jun 1, 2032
- Secondary endpoints: 26 to 25
- Site details revised at 1 of 4 sites
- Collaborators: 3 to 4
- Publications: details revised at 4 of 4 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (25)
Show 20 moreShow less
Arms and interventions
A phlebotomy (a procedure where the patient's blood is drawn, similar to a blood donation, without fluid replacement) at the start of the surgery combined with fluid restriction (use of vasopressor preferentially to treat hemodynamic instability with tolerance to relative hypovolemia defined as a Pulse Pressure Variation (PPV) or Stroke Volume (SVV) up to 18%). Fluids will be administered to compensate for blood loss and/or treat severe hemodynamic instability. Blood collected by phlebotomy will always be transfused back at the beginning of the reperfusion phase, during which fluid management will be based on goal-directed therapy (GDT) using either PPV or SV, as in the control group.
Goal-directed therapy (GDT): Patients will receive 250 ml fluid boluses until SV stops increasing by more than 10% or until PPV is below 12%. Fluids will thus be used preferentially to treat hemodynamic instability. Fluids will also be administered to compensate for blood loss and/or treat severe hemodynamic instability.
Procedures: Low splanchnic blood volume restrictive fluid management strategy, Phlebotomy, Optimized cardiac output liberal fluid management strategy
Sites
4 sites in 1 country